Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure
Suzanne Arends, Liseth de Wolff, Jolien F. van Nimwegen, Gwenny M. Verstappen, Jelle Vehof, Michele Bombardieri, Simon Bowman, Elena Pontarini, Alan N. Baer, Marleen Nys, Jacques‐Eric Gottenberg, Renaud Felten, Neelanjana Ray, Arjan Vissink, Frans G. M. Kroese, Hendrika Bootsma
Topics & Concepts
AbataceptMedicineRituximabClinical endpointRheumatismInternal medicineTocilizumabPhysical therapyClinical trialRheumatoid arthritisLymphomaSalivary Gland Disorders and FunctionsOcular Surface and Contact LensOcular Diseases and Behçet’s Syndrome